alovudine has been researched along with Rectal Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Datz, L; Fastner, G; Hauser-Kronberger, C; Holzmannhofer, J; Öfner, D; Pirich, C; Rendl, G; Rettenbacher, L; Sedlmayer, F | 1 |
| Chakravarthy, AB; Coffey, RJ; Engelman, JA; Manning, HC; McKinley, ET; Meyerhardt, JA; Walker, RC; Washington, MK; Watchmaker, JM | 1 |
| Dehdashti, F; Grigsby, PW; Ma, C; Myerson, RJ; Nalbantoglu, I; Siegel, BA | 1 |
| Becker, K; Geinitz, H; Lordick, F; Rosenberg, R; Rummeny, E; Schwaiger, M; Siewert, JR; Stahl, A; Stollfuss, J; Wieder, HA | 1 |
| Chang, ST; Gambhir, SS; Goodman, KA; Koong, AC; Loo, BW; McMillan, A; Patel, DA; Quon, A; Thorndyke, B | 1 |
2 trial(s) available for alovudine and Rectal Neoplasms
| Article | Year |
|---|---|
Positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study.
Topics: Adult; Aged; Chemoradiotherapy, Adjuvant; Dideoxynucleosides; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Rectal Neoplasms; Treatment Outcome | 2013 |
Impact of integrated PET/CT on variability of target volume delineation in rectal cancer.
Topics: Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Rectal Neoplasms; Tomography, X-Ray Computed | 2007 |
3 other study(ies) available for alovudine and Rectal Neoplasms
| Article | Year |
|---|---|
Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
[(18)F]-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot study.
Topics: Adult; Antineoplastic Agents; Cetuximab; Chemoradiotherapy; Dideoxynucleosides; Female; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Pilot Projects; Positron-Emission Tomography; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
PET imaging with [18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer.
Topics: Adult; Aged; Cell Proliferation; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Treatment Outcome | 2007 |